The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...
First formed in 1986, MAPS has the express purpose of working with the FDA and DEA to make MDMA-assisted talk therapy an approved, accepted, and available tool to treat PTSD. MAPS founder Rick ...
‘I needed help’: San Antonio study to use ecstasy for active-duty military members battling PTSD
The stage is being set for a San Antonio research team to use MDMA, also known as ecstasy, in its study to help active-duty ...
Jiangsu Hengrui Pharmaceuticals and its partner Elevar Therapeutics will have to wait even longer before their PD-1 inhibitor ...
LOS ANGELES -- The face of cancer is changing. More and more young adults between the ages of 18 and 49 are being diagnosed with cancers that were thought to affect mostly older patients.
The first few decades of adulthood are a time to focus on a career, make new friends, find a partner and maybe even travel. Cancer is not on that list. But with every passing year, aggressive ...
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder. By Andrew Jacobs After years of ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
A federal judge instructed the Trump administration to explain why its failure to turn around flights carrying deportees to El Salvador did not violate his court order. The Coconino County Sheriff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback